Thursday, April 21, 2011

Registration of clinical trials may benefit patients of mesothelioma

Site launched "EU clinical trials registration" recently for advertising and tracking and monitoring thousands of medical comprehensive patient trials. To continue the European Medicines Agency website, track the status and update information to the public. Already, the site was close to 7,000 trials.

Clinical trials are estimated at 10,000 in no time. These tests provide patients with different diseases the opportunity to test new treatments and benefit from the forefront of technological progress. Still have a lot of diseases are treated-these trials provide opportunities for advanced medical researchers and scientists, providers and patients to help make all curable diseases.

One of the disease without treating rare cancer known as mesothelioma. Mesothelioma affect about 3,000 Americans each year and 10 is estimated at 20,000 people worldwide. And "who" mesothelioma cases globally rising to 90,000 annually. This has much to do with the cause of mesothelioma, asbestos, toxic chemicals.

Asbestos was used extensively even in the United States between the 1920s and 1980s that gained the nickname "the backbone of the US industry" became known health risks of asbestos, diminished use. Currently, EPA regulates the use of asbestos and the removal of health and public safety. However, asbestos is not present so many buildings and structures, machinery and equipment, exposure is impossible.

Once inhaled asbestos fibers or addressed as motativi process begins in the lining of the abdominal cavities. Often in lung lining, put this operation for decades, often take twenty years to fifty to show recognizable symptoms. Many patients of mesothelioma cancer have no idea until other symptoms related to possibilities had been exhausted. Once you make a proper diagnosis, age between six months and two years. And mesothelioma treatments include medication, surgery, chemotherapy and radiation.

"Registered clinical trials site of the European Union currently lists sixteen mesothelioma related trials, including:" phase I/II study with sisblatine webimitrixid +/-soravinabe who in malignant mesothelioma, malignant mesothelioma treatment with Platinum (4 courses), followed by drug one Kelly (4 courses) + bimitrixid (firm) or bimitrixid (firm) + Platinum (4 sessions). "

European Commissioner for health and consumer policy, John Daly, a website: "record is good news for patients released and allowed to access information more easily about ongoing clinical trials in the European Union, and perhaps provide an important new treatment. It is of great importance to health care professionals, caregivers and research community and industry. "

This entry was posted on Tuesday 5 April 2011 at 6: 55 pm and is filed under General. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.

View the original article here

No comments:

Post a Comment